-
Fear on the Rise 06-16-2011
Thursday, June 16, 2011 - 6:56pm | 975Cusick's Corner Support held into the close and the After Hours finished in the green. Quad Witching is tomorrow where the options and futures all expire and the European options actually settle in the morning so there could be some maneuvering early based on the settlement. There is a lot of work...
-
Gene Sequencing's Advance Leads To Cloud
Thursday, June 16, 2011 - 5:44pm | 68Gene-sequencing instruments now can spit out so much data that some researchers are turning to cloud computing to handle the load -- lifting the outlook for providers of such services. PerkinElmer (PKI), a maker of scientific instruments, is one such company. It's expanding its services business...
-
Bottom-Picking - Leave It to the Proctologists 06-16-2011
Thursday, June 16, 2011 - 3:54pm | 1053Cusick's Corner I am not going to try to pick a bottom here but the landscape of the market is bearish. This move to the downside has potentially raised consumer hopes that this recent pullback in crude might (and I stress MIGHT) be reflected at the pump but I am not holding my breath. The equity...
-
Pressure BioSciences, Inc. Granted Extension to October 3, 2011 to Regain Compliance With NASDAQ Minimum Stockholders' Equity Requirement
Wednesday, June 15, 2011 - 9:28am | 140Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company received a notice from NASDAQ on June 10, 2011 granting it an extension of time until October 3, 2011 to regain compliance with the NASDAQ minimum stockholders' equity requirement of $2.5 million. On April 6, 2011, the...
-
A Peek Into The Market Before The Trading Starts
Wednesday, June 15, 2011 - 7:27am | 416Pre-open movers US stock futures are lower this morning, as investors are awaiting economic data. Futures on the Dow Jones Industrial Average dipped 53 points to 11,965.00 and futures on the S&P 500 stock index fell 6.40 points to 1,278.10. Nasdaq 100 futures dropped 11.50 points to 2,235.50...
-
PURE Bioscience Obtains NSF Registration for PURE Hard Surface as No-Rinse Sanitizer in Food Processing Areas
Wednesday, June 15, 2011 - 7:05am | 130PURE Bioscience, Inc. (NASDAQ: PURE) today announced it has obtained registration by NSF International of its SDC-based PURE™ Hard Surface disinfectant and food contact surface sanitizer for use as a no-rinse sanitizer in food processing areas. The NSF Nonfood Compounds Registration is a...
-
pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma
Tuesday, June 14, 2011 - 9:30am | 206Drug delivery company pSivida Corp. (NASDAQ: PSDV) today announced the commencement of a Phase I/II clinical trial studying a new bioerodible drug delivery implant for the treatment of glaucoma and ocular hypertension. The implant is designed to provide long-term, sustained release of latanoprost,...
-
pSivida and Pfizer Amend Agreement to Focus Solely on Development of Sustained-Release Implant to Deliver Latanoprost
Tuesday, June 14, 2011 - 9:08am | 86Drug delivery company pSivida Corp (NASDAQ: PSDV) today announced it amended and restated its Research and Development Agreement with Pfizer Inc. (NYSE: PFE) to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and...
-
Calls Purchased on Thermo Fisher Scientific
Monday, June 13, 2011 - 3:27pm | 110Shares of Thermo Fisher Scientific (NYSE: TMO) are lower on the session by 0.48%, currently trading at $62.54. The stock has been moving largely higher over the past three months and is currently trading above the 50-day moving average. Options traders are buying calls on the name today. Though...
-
Health Care Sector Showing Strength
Monday, June 13, 2011 - 1:28pm | 382The Health Care Sector is the strongest area of the market in today's trading session, currently up 0.5% on the day. The best performing stocks in the S&P 500 Health Care Sector currently are: 1) Forest Laboratories (NYSE: FRX): Shares of Forest Laboratories are currently trading up 1.8% from...
-
Rodman & Renshaw Outperform On Enzo Biochem
Friday, June 10, 2011 - 12:22pm | 115Rodman & Renshaw has an Outperform rating and a $7 price target on shares of Enzo Biochem Inc (NYSE: ENZ). In a note to clients, Rodman & Renshaw writes, "We are reiterating our Market Outperform / Speculative Risk rating and 12-month target price of $7, based on a 2015 discounted...
-
Rodman & Renshaw Reiterates Enzo Biochem Market Outperform, $7 PT
Friday, June 10, 2011 - 12:13pm | 95Rodman & Renshaw reiterated its Enzo Biochem (NYSE: ENZ) Market Outperform and $7 price target in a research report published today. In the report, Rodman & Renshaw states, "In keeping with our thesis, we believe there exists potential for additional novel diagnostic tests such as...
-
Enzo Biochem's Clinical Lab Acquires Marketing Rights to More Effective Diagnostic Test for Cervical Cancer
Friday, June 10, 2011 - 7:31am | 108Enzo Biochem Inc. (NYSE: ENZ) announced that its Enzo Clinical Labs subsidiary has reached an agreement with IncellDx Inc. of Menlo Park, CA, for the rights to market a proprietary laboratory test. The test is based upon HPV OncoTect™, an advanced molecular diagnostic technology for quantifying...
-
Accelr8 States That Its Policy Is Not to Comment on Unusual Market Activity or Rumors
Thursday, June 9, 2011 - 11:55am | 52In view of the unusual market activity in the stock of Accelr8 Technologies Corp (NYSE: AXK), the NYSE has contacted the company in accordance with its usual practice; the company stated that its policy is not to comment on unusual market activity or rumors.
-
PURE Bioscience Names Craig Johnson as Chief Financial Officer
Thursday, June 9, 2011 - 9:10am | 177PURE Bioscience (NASDAQ: PURE) announces the appointment of Craig Johnson as Chief Financial Officer, effective August 1, 2011. Mr. Johnson has more than 15 years' experience as a senior financial executive in the healthcare industry. Mr. Johnson has been Chief Financial Officer of two publicly...